Muscle weakness in mechanically ventilated patients with severe asthma.

Patients who undergo mechanical ventilation for severe asthma are at risk of developing diffuse muscle weakness because of acute myopathy. The relative importance of corticosteroids and neuromuscular paralysis in causing the myopathy is controversial, and it is uncertain whether the chemical structure of the drug used to induce paralysis influences the risk of myopathy. Using a retrospective cohort study design, we evaluated 107 consecutive episodes of mechanical ventilation for severe asthma to assess (1) the incidence of clinically significant weakness in patients treated with corticosteroids alone versus corticosteroids with neuromuscular paralysis, (2) the influence of the duration of paralysis on the incidence of muscle weakness, and (3) the relative risk of weakness in patients paralyzed with the nonsteroidal drug atracurium versus an aminosteroid paralytic agent (pancuronium, vecuronium). The use of corticosteroids and a neuromuscular blocking agent was associated with a much higher incidence of muscle weakness as compared with the use of corticosteroids alone (20 of 69 versus O of 38, p < 0.001). The 20 weak patients were paralyzed significantly longer than the 49 patients who received a neuromuscular blocking agent without subsequent weakness (3.4 +/- 2.4 versus 0.6 +/- 0.7 d, p < 0.001). Eighteen of the 20 weak patients had been paralyzed for more than 24 h. The incidence of weakness was not reduced when paralysis was achieved with atracurium as opposed to an aminosteroid neuromuscular blocking agent. In conclusion, corticosteroid-treated patients with severe asthma who undergo prolonged neuromuscular paralysis are at significant risk for the development of muscle weakness, and the risk of weakness is not reduced by use of atracurium.

[1]  D. Lacomis,et al.  Acute myopathy and neuropathy in status asthmaticus: Case report and literature review , 1993, Muscle & nerve.

[2]  D. DuBois,et al.  A possible role for glucocorticoids in denervation atrophy , 1981, Muscle & nerve.

[3]  Y. Kupfer,et al.  Disuse atrophy in a ventilated patient with status asthmaticus receiving neuromuscular blockade. , 1987, Critical care medicine.

[4]  D. Coursin,et al.  Acute myopathy during treatment of status asthmaticus with corticosteroids and steroidal muscle relaxants. , 1992, Chest.

[5]  P. Kaplan,et al.  Acute steroid-induced tetraplegia following status asthmaticus. , 1986, Pediatrics.

[6]  D. Tuxen.  Permissive hypercapnic ventilation. , 1994, American journal of respiratory and critical care medicine.

[7]  M. Horne,et al.  Acute myopathy in severe acute asthma treated with intravenously administered corticosteroids. , 1988, The American review of respiratory disease.

[8]  M. Muers,et al.  Acute hydrocortisone myopathy in acute severe asthma. , 1986, Thorax.

[9]  C. Minetti,et al.  Acute quadriplegic myopathy , 1992, Neurology.

[10]  B. Margolis,et al.  Prolonged reversible quadriparesis in mechanically ventilated patients who received long-term infusions of vecuronium. , 1991, Chest.

[11]  R. Prielipp,et al.  Prolonged weakness after infusion of atracurium in two intensive care unit patients. , 1994, Anesthesia and analgesia.

[12]  S. Subramony,et al.  Myopathy and prolonged neuromuscular blockade after lung transplant , 1991, Critical care medicine.

[13]  C. Manthous,et al.  Prolonged weakness after the withdrawal of atracurium. , 1994, American journal of respiratory and critical care medicine.

[14]  J. Hansen-Flaschen,et al.  Neuromuscular blockade in the intensive care unit. More than we bargained for. , 1993, The American review of respiratory disease.

[15]  M. Weinmann,et al.  Myopathy in severe asthma. , 1992, The American review of respiratory disease.

[16]  S. Carpenter,et al.  Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatment , 1991, Muscle & nerve.

[17]  C. Perret,et al.  Permissive hypercapnia. How permissive should we be? , 1994, American journal of respiratory and critical care medicine.

[18]  S. Carpenter,et al.  Glucocorticoid excess induces preferential depletion of myosin in denervated skeletal muscle fibers , 1987, Muscle & nerve.

[19]  M. Magistris,et al.  Neuromuscular disorder in intensive care unit patients treated with pancuronium bromide. Occurrence in a cluster group of seven patients and two sporadic cases, with electrophysiologic and histologic examination. , 1994, Chest.

[20]  C. Bolton,et al.  Critical illness polyneuropathy. A complication of sepsis and multiple organ failure. , 1987, Brain : a journal of neurology.

[21]  I. MacFarlane,et al.  SEVERE MYOPATHY AFTER STATUS ASTHMATICUS , 1977, The Lancet.